Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR

American Journal of Gastroenterology

Volumn 100, Issue 2, 2005, Pages 373-382

  Malinen, Erja ^b   Rinttilä, Teemu ^b   Kajander, Kajsa ^b   Mättö, Jaana ^b   Kassinen, Anna ^b   Krogius, Lotta ^b   Saarela, Maria ^b   Korpela, Riitta ^b   Palva, Airi ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BIFIDOBACTERIUM; BIFIDOBACTERIUM CATENULATUM; CAMPYLOBACTER JEJUNI; CLINICAL ARTICLE; CLINICAL FEATURE; CLOSTRIDIUM; CLOSTRIDIUM COCCOIDES; CLOSTRIDIUM DIFFICILE; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DNA DETERMINATION; DNA SEQUENCE; FECES ANALYSIS; FECES MICROFLORA; FEMALE; GASTROINTESTINAL SYMPTOM; HELICOBACTER; HUMAN; IRRITABLE COLON; LACTOBACILLUS; MALE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SYMPTOM; VEILLONELLA; BACTERIUM; FECES; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; POLYMERASE CHAIN REACTION;

BACTERIAL DNA;

ADULT; AGED; BACTERIA; DNA, BACTERIAL; FECES; FEMALE; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA;

EID: 13944255868     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2005.40312.x     Document Type: Article

References (37)

1. Drossman DA, Camilleri M, Mayer EA, et al. AGA technical review on irritable bowel syndrome. Gastroenterology 2002;123:2108-31.
2. McKendrick MW, Read NW. Irritable bowel syndrome-post salmonella infection. J Infect 1994;29:1-3.
3. Neal KR, Hebden J, Spiller RC. Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: Postal survey of patients. Br Med J 1997;314:779-82.
4. Rodríguez LAG, Ruigomez A, Increased risk of irritable bowel syndrome after bacterial gastroenteritis: Cohort study. Br Med J 1999;318:565-6.
5. Chadwick VS, Chen W, Shu D, et al. Activation of the mucosal immune system in irritable bowel disease. Gastroenterology 2002;122:1778-83.
6. Balsari A, Ceccarelli A, Dubini F, et al. The fecal microbial population in the irritable bowel syndrome. Microbiologica 1982;5:185-94.
7. King TS, Elia M, Hunter JO. Abnormal colonic fermentation in the irritable bowel syndrome. Lancet 1998;352:1187-9.
8. Pimentel M, Chow EJ, Lin HC. Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome: A double-blind, randomized, placebo-controlled study. Am J Gastroenterol 2003;98:412-9.
9. Treem WR, Ahsan N, Kastoff G, et al. Fecal short-chain fatty acids in patients with diarrhea-predominant irritable bowel syndrome: In vitro studies of carbohydrate fermentation. J Pediatr Gastroenterol Nutr 1996;23:280-6.
10. Langendijk PS, Schut F, Jansen GJ, et al. Quantitative fluorescence in situ hybridization of Bifidobacterium spp. with genus-specific 16S rRNA-targeted probes and its application in fecal samples. Appl Environ Microbiol 1995;61:3069-75.
11. Suau A, Bonnet R, Sutren M, et al. Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl Environ Microbiol 1999;65:4799-807.
12. Thompson WG, Longstreth GF, Drossman DA, et al. Functional bowel disorders and functional abdominal pain. Gut 1999;45(Suppl 2):43-7.
13. Apajalahti JHA, Särkilahti LK, Mäki BRE, et al. Effective recovery of bacterial DNA and percent-guanine-plus-cytosine-based analysis of community structure in the gastrointestinal tract of broiler chickens. Appl Environ Microbiol 1998;68:4084-8.
14. Seksik P, Rigottier-Gois L, Gramet G, et al. Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut 2003;52:237-42.
15. Wensinck F. The faecal flora of patients with Crohn's disease. Antonie van Leeuwenhoek 1975;41:214-5.
16. Stebbings S, Munro K, Simon MA, et al. Comparison of the faecal microflora of patients with ankylosing spondylitis and controls using molecular methods of analysis. Rheumatology 2002;41:1395-401.
17. Kirjavainen PV, Apostolou E, Arvola T, et al. Characterizing the composition of intestinal microflora as a prospective treatment target in infant allergic disease. FEMS Immunol Med Microbiol 2001;32:1-7.
18. Watanabe S, Narisawa Y, Arase S, et al. Differences in fecal microflora between patients with atopic dermatitis and healthy control subjects. J Allergy Clin Immunol 2003;111:587-91.
19. Giacometti A, Cirioni O, Fiorentini A, et al. Irritable bowel syndrome in patients with Blastocystis hominis. Eur J Clin Dis 1999;18:436-9.
20. Brigidi P, Vitali B, Swennen E, et al. Effects of probiotic administration upon the composition and enzymatic activity of human fecal microbiota in patients with irritable bowel syndrome or functional diarrhea. Res Microbiol 2001;152:735-41.
21. Niedzielin K, Kordecki H, Birkenfeld B. A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol 2001;13:1143-7.
22. Nobaek S, Johansson ML, Molin G, et al. Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. Am J Gastroenterol 2000;95:1231-8.
23. Hungin APS, Whorwell PJ, Tack J, et al. The prevalence, patterns and impact of irritable bowel syndrome; an international survey of 40 000 subjects. Aliment Pharmacol Ther 2003;17:643-50.
24. Kimura K, McCartney AL, McConnel MA, et al. Analysis of fecal populations of bifidobacteria and lactobacilli and investigation of the immunological responses of their human hosts to the predominant strains. Appl Environ Microbiol 1997;63:3394-8.
25. McCartney AL, Wenzhi W, Tannock GW. Molecular analysis of the composition of the bifidobacterial and lactobacillus microflora of humans. Appl Environ Microbiol 1996;62:4608-13.
26. Spiller RC, Jenkins D, Thornley JP, et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 2000;47:804-11.
27. Neal KR, Barker L, Spiller RC. Prognosis in post-infective irritable bowel syndrome: A six year follow up study. Gut 2002;51:410-3.
28. Hellard ME, Sinclair MI, Hogg GG, et al. Prevalence of enteric pathogens among community based asymptomatic individuals. J Gastroenterol Hepatol 2000;15:290-3.
29. Lawson AJ, Linton D, Stanley J. 16S rRNA gene sequences of 'Candidates Campylobacter hominis', a novel uncultivated species, are found in the gastrointestinal tract of healthy humans. Microbiology 1998;144:2063-71.
30. Su YC, Wang WM, Wang SY, et al. The association between Helicobacter pylori infection and functional dyspepsia in patients with irritable bowel syndrome. Am J Gastroenterol 2000;95:1900-5.
31. Locke GR, Talley NJ, Nelson DK, et al. Helicobacter pylori and dyspepsia: A population-based study of the organism and host. Am J Gastroenterol 2000;95:1906-13.
32. Kosunen TU, Aromaa A, Rnekt P, et al. Helicobacter antibodies in 1973 and 1994 in the adult population in Vammala, Finland. Epidemiol Infect 1997;119:29-34.
33. Rintill T, Kassinen A, Halinen E, et al. Development of an extensive set of 165 + DNA-targeted primers for quantification of pathogenic and indigenous bacterias in faecal samples by real-time PCR. J Appl Microbiol 2004;97:1166-77.
34. Malinen E, Kassinen A, Rinttilä T, et al. Comparison of real-time PCR with SYBR Green I or 5′-nuclease assays and dot-blot hybridization with rDNA-targeted oligonucleotide probes in quantification of selected faecal bacteria. Microbiology 2003;149:269-77.
35. Walter J, Hertel C, Tannock GW, et al. Detection of Lactobacillus, Pediococcus, Leuconostoc, and Weissella species in human feces by using group-specific PCR primers and denaturing gradient gel electrophoresis. Appl Environ Microbiol 2001;67:2578-85.
36. Heilig HG, Zoetendal EG, Vaughan EE, et al. Molecular diversity of Lactobacillus spp. and other lactic acid bacteria in the human intestine as determined by specific amplification of 16S ribosomal DNA. Appl Environ Microbiol 2002;68:114-23.
37. Matsuki T, Watanabe K, Tanaka R, et al. Distribution of bifidobacterial species in human intestinal microflora examined with 16S rRNA-gene-targeted species-specific primers. Appl Environ Microbiol 1999;65:4506-12.